In 1993 a locus for JOAG was mapped to the 1q21-q31 region and assigned as GLC1A. 6 Shortly after that, linkage to the GLC IA region was confirmed in additional glaucoma families with different genetic background.7 8 Genetic heterogeneity at the locus has also been established; some reports described linkage to the 1 q2 l-q3 1 region in families with both JOAG and adult onset POAG.78
Recently, mutations in trabecular meshwork induced glucocorticoid response protein (TIGR) (also known as myocilin or MYOC) were identified as a cause of the glaucoma phenotype linked to the GLC 1A locus.9 TIGR was shown to be expressed in trabecular meshwork, ciliary body, retina, sclera, choroid, and in some extraocular tissues such as mammary gland, thymus, testis, heart, and skeletal muscles."0-" This gene has been implicated to be involved in the pathophysiology of glaucoma by causing obstruction of the aqueous outflow with its product, resulting in an increased intraocular pressure.8 "' More recently, we described a novel mutation (Gln337Arg) in one large JOAG family from Edinburgh, Scotland.'4 In addition to this, the role of TIGR/MYOC in the aetiology of POAG was confirmed in other families from France,'2 Japan," and Germany. '6 In this report, we describe novel mutations in British and French-Canadian families affected with typical JOAG. We also present a Turkish family with the same condition, which is apparently linked to the 1q21-q31 region, but lacks mutations in any of the coding regions of the TIGR gene.
We studied four Caucasian pedigrees segregating for the JOAG phenotype (fig 1) . Two of the families were English (POAG-3 and POAG-3 1), one was French-Canadian (POAG-50 1), and another Turkish (POAG-801). The glaucoma phenotype was transmitted as an autosomal dominant trait with no apparent skipped generations.
Material and methods Blood samples or buccal cells from mouth washes were obtained from all family members who volunteered to participate and DNA was extracted. We used a number of STRP markers flanking the GLC1A locus for PCR amplification. The chromosomal order of these markers, PCR, conditions for electrophoresis, and silver staining have been described previously.'4 The genotypic data obtained were entered into a dedicated computer program (DMS) and checked for inconsistency. Haplotypes were constructed based on the assumption of a minimal number of recombination events. All four families showed evidence of linkage to the GLC1A region.
After linkage was established to the GLC IA locus, we screened the TIGR gene by single strand conformational polymorphism (SSCP) analysis or by direct sequencing of the PCR products using dRhodamine chemistry and (fig 2) . Analysis of this restriction site showed that the only phenotypically normal person (II.3) who was carrying the affected haplotype (data not shown) lacks the AlwNI restriction site. In order to confirm the lack of the C-4T transition, genomic DNA of this subject was PCR amplified and directly sequenced. Only the normal "C" was detected at the expected nucleotide position 1109. This result indicated that Pro37OLeu has occurred spontaneously in II.1, and thereafter had been passed on as a causative mutation to the two subsequent generations. The second change found in this family was the Tyr347Tyr polymorphism as previously described by Stone et al. 9 We screened 53 healthy subjects from the general population for the presence of the above mentioned sequence variants (Al 139C, T1504C, and C1109T). None of the normal controls was carrying any of the mutations, supporting their causative role in the glaucoma phenotype.
Discussion
It is now generally accepted that glaucoma encompasses a group of both clinically and genetically heterogeneous disorders resulting from mutations in different single genes or by interaction of multiple genes. Two such genes have already been identified. CYPlBl (cytochrome P4501B1) was identified as the gene causing primary congenital glaucoma (the GLC3A locus) in the 2p21 region,'8 19 and mutations in TIGR have been reported to be responsible for the glaucoma phenotype in POAG families linked to the 1 q21-q31 region."9 [14] [15] [16] [17] The TIGR protein contains a myosin-like domain at the N-terminus and an olfactomedin-like domain in its C-terminus, suggesting that TIGR is an extracellular matrix component possibly involved in protein/protein interactions.8..' 13 All the mutations reported to date are in the third exon of this gene, corresponding to the olfactomedin domain, which may interfere with the binding activity of the protein. This could result in abnormalities in the uptake or metabolism of the gene product, leading to accumulation of protein and obstruction of the aqueous outflow, which can cause increased IOP and damage to the optic nerve. 8 In this study, we screened the entire coding region together with the exon/intron boundaries of the TIGR gene for possible mutations in four Caucasian families with typical JOAG. As a result of our investigation, four different amino acid substitutions were detected. Three of them, Pro37OLeu, Asp38OAla, and Ser5O2Pro, are causative mutations in three families, while the Arg76Lys was proven to be an amino acid polymorphism. Two of the mutations observed in this study, Pro37OLeu and Asp38OAla, are in the region corresponding to the olfactomedin-like domain; however, Ser5O2Pro falls outside this region. To the best of our knowledge, both Asp38OAla and Ser502Pro are novel mutations and have not been reported in other families.
Interestingly, the Pro37OLeu substitution that was found in our French-Canadian family was also reported in French,'2 Japanese,'5 and German'6 families. This mutation has occurred in the context of a CpG dinucleotide and it is more likely to be a recurrent rather than a founder one. Indeed, we provided evidence that the Pro37OLeu mutation in our POAG-501 family has occurred spontaneously and subsequently passed on in a causative manner to the next two generations (fig 2) .
We also presented a Turkish family with a typical JOAG phenotype that lacks any mutations in the entire coding sequence and the intron/exon junctions of the TIGR/MYOC gene. However, it is possible that mutation in the control regions of TIGR or another neighbouring gene accounts for the disease phenotype in this family. Considering the relatively small size of this family, it is also possible that this kindred maps to another region of the genome and, therefore, the observed JOAG phenotype is a phenocopy in this family that is caused by mutation in a gene as yet unknown.
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